Greg Bennett
Pharma Regulatory Intelligence for Hedge Funds | EU/US FDA-EMA-TGA |
- Role
- Founder at Arclane Intelligence
- Location
- Seattle, WA, US
- LinkedIn followers
- 500 followers
About Greg Bennett
I build regulatory timing intelligence for healthcare investors.Arclane converts global regulatory disclosures into structured, tradable signal architecture for institutional desks.Focus areas:• EMA / FDA / TGA cross-market surveillance• Catalyst sequencing models• Regulatory pattern recognition• Probability-weighted event trackingHealthcare equities are governed by regulatory mechanics.Understanding those mechanics before consensus does is the edge we provide our clients.
Experience
Founder
Jul 2025 — Present · Seattle, WA, US
Primary-source regulatory intelligence for hedge funds and institutional investors.We operate upstream of consensus, by monitoring EU and US agencies where market-moving decisions publish first, before terminals and press distribute the story.We deliver desk-ready alerts and regulatory due diligence designed for positioning, hedging, and risk control — not noise.Recent work includes:Regulatory diligence for private equity evaluating $500M+ pharma exposureReal-time EU/FDA monitoring built for healthcare long/short podsProprietary research on EMA–FDA convergence patterns and safety escalation regimesExpansion underway:Distressed credit early-warning (UK administration, US Chapter 11)Australia TGA monitoring and cross-border timing feedsWe don’t sell information.We sell first look.Information arrives. Price follows.
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.